Related by context. All words. (Click for frequent words.) 79 sorafenib 76 vandetanib 74 imatinib 74 bevacizumab 74 topotecan 73 azacitidine 73 gemcitabine 73 docetaxel chemotherapy 73 docetaxel 72 rituximab 72 metastatic renal cell carcinoma 72 axitinib 72 cetuximab 72 temozolomide 72 erlotinib 72 Fludara 72 lapatinib 71 temsirolimus 71 bortezomib 71 trastuzumab 71 anti TNF 71 mycophenolate mofetil 71 bevacizumab Avastin 70 tocilizumab 70 pemetrexed 70 Vectibix 70 imatinib therapy 70 pazopanib 70 decitabine 70 pertuzumab 70 chlorambucil 70 bendamustine 70 mRCC 70 TORISEL 70 standard chemotherapy regimens 70 abatacept 70 adalimumab 70 dasatinib 69 gefitinib 69 sorafenib Nexavar 69 metastatic RCC 69 FOLFOX4 69 pomalidomide 69 peginterferon 69 Sutent 69 sunitinib malate 69 Dasatinib 69 dacarbazine 69 Torisel 69 candesartan 69 Doxil ® 69 iniparib 69 Taxotere ® 69 FOLFIRI 68 irinotecan 68 Nexavar 68 capecitabine 68 SUTENT 68 standard chemotherapy regimen 68 Sorafenib 68 chemoradiotherapy 68 CIMZIA TM 68 mitoxantrone 68 monotherapy 68 fondaparinux 68 BAY #-# 68 tipranavir 68 mapatumumab 68 HER2 positive metastatic breast 68 fludarabine 68 cabazitaxel 68 VIDAZA 68 Amrubicin 68 anastrozole 68 IRESSA 67 cilengitide 67 neoadjuvant chemotherapy 67 carboplatin paclitaxel 67 advanced NSCLC 67 mg kg dose 67 insulin glargine 67 nilotinib 67 posaconazole 67 relapsed multiple myeloma 67 olaparib 67 Taxotere R 67 relapsed CLL 67 heavily pretreated 67 APTIVUS r 67 chronic lymphocytic leukemia CLL 67 metastatic colorectal cancer 67 anti leukemic 67 levosimendan 67 trabectedin 67 ganetespib 67 interferon alfa 67 TACE 67 FOLFOX 67 interferon alpha 67 pegylated interferon 67 cediranib 67 enzastaurin 67 nab paclitaxel 67 panitumumab 67 vinorelbine 67 regorafenib 67 anakinra 67 aflibercept 67 fulvestrant 67 TNF inhibitors 67 Cetuximab 66 pegylated interferon alpha 66 lumiliximab 66 elotuzumab 66 XELOX 66 pegylated liposomal doxorubicin 66 zoledronic acid 66 CIMZIA ™ 66 fluorouracil 66 ribavirin RBV 66 carboplatin 66 phase IIb clinical 66 ATACAND 66 bevacizumab Avastin ® 66 olmesartan 66 lapatinib Tykerb 66 TNF inhibitor 66 Pemetrexed 66 zalutumumab 66 glatiramer acetate 66 Mylotarg 66 gemcitabine chemotherapy 66 Erlotinib 66 seliciclib 66 DAPT 66 PREZISTA r 66 vicriviroc 66 5-FU/LV 66 Xeloda 66 cisplatin 66 lamivudine 66 gefitinib Iressa 66 PegIFN RBV 66 teriflunomide 66 liposomal doxorubicin 66 Bevacizumab 66 pegylated interferon alfa 2b 66 gemcitabine carboplatin 66 biologic therapy 66 HuMax CD4 66 valsartan 66 COPAXONE R 66 rosuvastatin 66 DMARD 66 irbesartan 66 oxaliplatin 66 adecatumumab 66 Sunitinib 66 DMARDs 65 relapsed ovarian cancer 65 telmisartan 65 glufosfamide 65 sorafenib Nexavar ® 65 metastatic HRPC 65 TYKERB 65 methotrexate therapy 65 pioglitazone 65 Telcyta 65 infliximab 65 adalimumab Humira 65 peginterferon alfa 2a 65 mTOR inhibitor 65 tanespimycin 65 aliskiren 65 Tarceva erlotinib 65 figitumumab 65 romiplostim 65 Avastin 65 allopurinol 65 ACE inhibitor 65 plus dexamethasone 65 YONDELIS 65 everolimus 65 LMWH 65 peg interferon 65 letrozole 65 HGS# 65 eplerenone 65 etanercept 65 receptor tyrosine kinase inhibitor 65 metformin 65 abiraterone acetate 65 DMARD therapy 65 CA4P 65 lenalidomide 65 ticagrelor 65 DOXIL 65 plus ribavirin 65 apremilast 65 PXD# 65 Hycamtin 65 Amigal 65 idarubicin 65 docetaxel Taxotere ® 65 Herceptin trastuzumab 65 cetuximab Erbitux 65 FTY# 65 methotrexate 65 ACTEMRA TM 65 Gemcitabine 65 docetaxel Taxotere 65 adefovir 65 sunitinib Sutent 65 tyrosine kinase inhibitor 65 Pegasys ® 65 Taxotere 65 Irinotecan 65 obatoclax 65 abiraterone 65 raltegravir 65 NSCLC 65 imetelstat 65 Dacogen injection 65 riociguat 65 randomized Phase III 65 galiximab 65 REMICADE ® 65 tolvaptan 65 ritonavir boosted 65 pegylated interferon alfa 2a 65 clopidogrel 65 epoetin alfa 65 azathioprine 65 5 FU 64 imatinib mesylate 64 mCRC 64 lupus nephritis 64 panitumumab Vectibix 64 ipilimumab 64 Aplidin 64 AEGR 64 HGS ETR1 64 ZOLINZA 64 IFN α 64 erlotinib Tarceva ® 64 MGd 64 chemoradiation 64 Peg IFN 64 cytotoxic chemotherapy 64 tiotropium 64 tamoxifen therapy 64 PegIntron 64 RG# [001] 64 T DM1 64 afatinib 64 alteplase 64 virologic failure 64 TTF Therapy 64 bosentan 64 platinum refractory 64 etoposide 64 chemotherapy regimen 64 relapsed refractory multiple myeloma 64 Aptivus ® 64 non squamous NSCLC 64 estramustine 64 Nexavar sorafenib 64 APPRAISE 64 peg IFN 64 paclitaxel 64 refractory CLL 64 #mg dose [001] 64 edoxaban 64 chemotherapy regimens 64 Jevtana 64 ocrelizumab 64 cetuximab Erbitux ® 64 active comparator 64 imatinib Gleevec 64 bicalutamide 64 recurrent GBM 64 EGFR TKI 64 alkylating agent 64 Vidaza 64 GVAX 64 TKI therapy 64 APTIVUS 64 melphalan prednisone 64 Trastuzumab 64 tesmilifene 64 exemestane 64 carvedilol 64 chemotherapy docetaxel 64 BEACOPP 64 dose escalation 64 HCV RESPOND 2 64 heavily pretreated patients 64 atazanavir 64 CoFactor 64 NATRECOR R 64 Imatinib 64 adjuvant therapy 64 nitazoxanide 64 sirolimus 64 hypomethylating agents 64 ramipril 64 Atacand 64 paclitaxel carboplatin 64 ACZ# 64 viral kinetics 64 peginterferon alfa 2b 64 chronic myeloid leukemia CML 64 superficial bladder cancer 64 forodesine 64 pegylated interferon alfa 64 Tarceva 64 lintuzumab 64 Gefitinib 64 complete cytogenetic response 64 mCRC patients 64 Tarceva TM 64 VICTRELIS 64 interferon therapy 64 Bortezomib 64 leukemia CLL 64 daclizumab 64 antihypertensive agents 64 noninferiority 64 antihypertensive drugs 64 HuMax EGFr 64 Navelbine 64 PROMACTA 63 Doxil 63 tofacitinib 63 visilizumab 63 IMC A# 63 relapsed MM 63 surrogate endpoint 63 antihypertensive therapy 63 LEXIVA r 63 REVLIMID 63 doxorubicin docetaxel 63 sorafenib tablets 63 Traficet EN 63 SCCHN 63 5 fluorouracil 63 RoACTEMRA 63 motesanib 63 amrubicin 63 Allovectin 7 ® 63 low dose cytarabine 63 CHOP chemotherapy 63 vismodegib 63 relapsed SCLC 63 disease progression 63 tamoxifen 63 cetuximab Erbitux R 63 eltrombopag 63 entecavir 63 Copegus ribavirin 63 dabigatran etexilate 63 Afinitor 63 Halaven 63 administered subcutaneously 63 Rituximab 63 SCH # 63 CBLC# 63 dosage regimens 63 ustekinumab 63 Gleevec 63 refractory AML 63 preoperative chemotherapy 63 angiogenesis inhibitor 63 TNF antagonist 63 CLL8 63 HCV SPRINT 63 MabCampath 63 ISENTRESS 63 losartan 63 unresectable 63 Aromasin 63 leucovorin 63 vemurafenib 63 darunavir ritonavir 63 recurrent glioblastoma multiforme 63 lenalidomide Revlimid R 63 tenofovir emtricitabine 63 mg dose 63 Vandetanib 63 ASA# 63 SPRYCEL 63 Ixempra 63 alvespimycin 63 Velcade 63 ZACTIMA 63 5FU 63 follicular NHL 63 pegfilgrastim 63 Revlimid 63 oral rivaroxaban 63 Tykerb 63 YERVOY 63 talabostat 63 fluvastatin 63 antiangiogenic therapy 63 OncoVEX GM CSF 63 Telintra 63 neoadjuvant 63 ixabepilone 63 angiotensin receptor blocker ARB 63 sipuleucel T 63 rilonacept 63 fostamatinib 63 taxane 63 CellCept 63 immunosuppressant 63 infusional 5-FU/LV 63 INTELENCE 63 intermittent dosing 63 perifosine 63 TroVax 63 evaluating tivozanib 63 fluoropyrimidine 63 metastatic castration resistant 63 cytarabine 63 TNFerade 63 ELACYT 63 oral anticoagulant 63 Laquinimod 63 clodronate 63 methotrexate MTX 63 LY# [003] 63 Xcytrin 63 metastatic CRC 63 antitumor effect 63 Xinlay 63 mcg kg 63 anthracycline taxane 63 elacytarabine 63 pancreatic NET 63 NRTI 63 phase Ib 63 XGEVA 63 cinacalcet 63 insulin detemir 63 dutasteride 63 maraviroc 63 dose dexamethasone 63 Avastin bevacizumab 63 virologic 63 dexamethasone Decadron 63 MIRCERA 63 Cytoxan 63 G CSF 63 Votrient 63 omalizumab 63 Yervoy 63 Tasigna 63 metastatic malignant melanoma 63 Targretin 63 β blockers 62 LymphoStat B 62 registrational trial 62 CANCIDAS 62 teriparatide 62 glargine 62 tacrolimus 62 bortezomib Velcade 62 plus prednisone 62 atrasentan 62 calcitriol 62 crizotinib PF # 62 Clolar 62 lopinavir r 62 FOLPI 62 Dose escalation 62 TELCYTA 62 metastatic hormone refractory 62 VELCADE 62 HRPC 62 HGS ETR2 62 multicentre randomized 62 gastrointestinal stromal tumor GIST 62 Nexavar ® 62 BARACLUDE 62 HSCT 62 unfractionated heparin 62 Cloretazine 62 IFN alfa 62 fosbretabulin 62 Adalimumab 62 LPV r 62 daunorubicin 62 TEMODAL 62 Ceflatonin 62 Omacetaxine 62 phase IIb 62 relapsing multiple sclerosis 62 ribavirin therapy 62 RRMS patients 62 CAELYX 62 uric acid lowering 62 darapladib 62 Velcade bortezomib 62 dasatinib Sprycel ® 62 spironolactone 62 free survival PFS 62 antiplatelet therapy 62 febuxostat 62 doxorubicin 62 goserelin 62 virological failure 62 anthracyclines 62 Tamibarotene 62 neratinib 62 boosted protease inhibitor 62 FOLFOX6 62 metastatic GIST 62 sitagliptin 62 imatinib resistant 62 leukemia AML 62 docetaxel Taxotere R 62 pancreatic neuroendocrine tumors 62 ONGLYZA 62 Aflibercept 62 trastuzumab Herceptin 62 Zolinza 62 aldosterone antagonists 62 octreotide LAR 62 valopicitabine 62 capecitabine Xeloda 62 amphotericin B 62 VELCADE melphalan 62 bezafibrate 62 dose cytarabine 62 xanthine oxidase inhibitor 62 pegylated interferon peg IFN 62 peginterferon alfa 62 relapsed refractory 62 BRAF inhibitor 62 Navelbine ® 62 interferon 62 REVLIMID ® 62 Mipomersen 62 amlodipine 62 cisplatin chemotherapy 62 Pegylated Interferon 62 antithrombotic 62 HAART regimens 62 hematologic toxicity 62 rosiglitazone 62 bosutinib 62 Lenalidomide 62 Pfizer Sutent 62 lanthanum carbonate 62 VAPRISOL 62 TNF antagonists 62 antithrombotic therapy 62 vorinostat 62 alemtuzumab 62 taxane therapy 62 Revlimid lenalidomide 62 rindopepimut 62 Dapagliflozin 62 ximelagatran 62 neoadjuvant treatment 62 sustained virologic response 62 low dose dexamethasone 62 trabedersen 62 Telmisartan 62 KRAS mutant tumors 62 Folfox 62 eptifibatide 62 HuMax CD# 62 ranolazine 62 irinotecan chemotherapy 62 neoadjuvant therapy 62 stage IIIB 62 Gleevec imatinib 62 IV NSCLC 62 BRIM2 62 KRAS status 62 AMN# [001] 62 Xanafide 62 cytokine refractory 62 motavizumab 62 darunavir 62 Capecitabine 62 cardiotoxicity 62 cardiac toxicity 62 natalizumab 62 Bronchitol 62 Phase Ib II 62 IFN beta 62 protease inhibitor 62 LUX Lung 62 ofatumumab 62 Femara letrozole 62 antidepressant therapy 62 relapsing MS 62 octreotide 62 SUTENT ® 62 enfuvirtide 62 aromatase inhibitor 62 dose cohorts 62 resistant ovarian cancer 62 erlotinib Tarceva 62 Plicera 62 recurrent NSCLC 62 velafermin 62 Hydroxyurea 62 eniluracil 62 dacarbazine chemotherapy 62 adjuvant tamoxifen 62 taxanes 62 paclitaxel Taxol 62 Phase Ib clinical 62 Azacitidine 62 oblimersen 62 Sandostatin LAR 62 indolent NHL 62 Vectibix monotherapy 62 placebo controlled clinical 62 Phenoptin 62 idraparinux 62 Lapatinib 62 epoetin 62 rt PA 62 oral FTY# 62 virologic response 62 abciximab 62 ISTODAX 62 Oxaliplatin 62 Triapine 62 Alemtuzumab 62 adjuvant chemotherapy 62 protease inhibitor PI 61 hydroxychloroquine 61 anthracycline therapy 61 anticancer therapy 61 PEG Interferon lambda 61 certolizumab 61 tipranavir ritonavir 61 phase IIb trial 61 eribulin mesylate 61 plus gemcitabine 61 dalteparin 61 CIMZIA TM certolizumab pegol 61 Golimumab 61 Alimta 61 BARACLUDE ® 61 Elitek 61 eculizumab 61 prospectively defined 61 recurrent ovarian cancer 61 alpha 2a 61 AVASTIN 61 disease modifying antirheumatic 61 oral ridaforolimus 61 Topotecan 61 placebo dexamethasone 61 Advagraf 61 Mitoxantrone 61 tipifarnib 61 ACTEMRA 61 dose regimens 61 Ceplene/IL-2 61 rivaroxaban 61 antiepileptic drug 61 leflunomide 61 canakinumab 61 Pegasys plus Copegus 61 NOXAFIL 61 IGIV 61 iclaprim 61 QTc prolongation 61 relapsing remitting multiple sclerosis 61 chemoradiation therapy 61 XL# SAR# 61 sulfonylurea 61 rFVIIa 61 ARB telmisartan 61 gemcitabine Gemzar 61 malignant pleural mesothelioma 61 Imprime PGG 61 Campath alemtuzumab 61 IMGN# 61 Betaferon ® 61 neurologic progression 61 glucose lowering 61 statin therapy 61 angiotensin converting enzyme inhibitors 61 Genasense 61 tecarfarin 61 Myelodysplastic Syndrome MDS 61 Herceptin 61 cytotoxic therapy 61 epirubicin 61 clozapine 61 celecoxib 61 Exjade 61 Bezielle 61 dosing regimens 61 Perforomist Inhalation Solution 61 Fludarabine 61 Pazopanib 61 ivabradine 61 EGFR expressing mCRC 61 FluCAM 61 Xelox 61 TMC# [001] 61 corticosteroid therapy 61 abacavir lamivudine 61 gastrointestinal stromal tumors GIST 61 Phase 2b study 61 TroVax ® 61 subcutaneously administered 61 metastatic melanoma 61 palonosetron 61 renal cell carcinoma 61 prasugrel 61 interferon alfa 2a 61 Pertuzumab 61 metastatic breast cancer 61 telaprevir dosed 61 CYT# 61 BMS # 61 ELOXATIN 61 statin 61 Erbitux cetuximab 61 trastuzumab Herceptin ® 61 sustained virological response 61 interferon ribavirin 61 oral allopurinol 61 median PFS 61 tirofiban 61 aflibercept VEGF Trap 61 Natalizumab 61 sulphonylurea 61 GnRH agonists 61 elesclomol 61 ibandronate 61 ZD# [001] 61 pegylated interferons 61 Perifosine 61 ULORIC 61 Tasigna nilotinib 61 calcineurin inhibitors 61 ON #.Na 61 NRTIs 61 OADs 61 fosamprenavir 61 refractory NSCLC 61 STRIDE PD 61 Monotherapy 61 VPRIV 61 EGFR inhibitors 61 ancrod 61 PRT# 61 Roche Xeloda 61 Everolimus 61 Dacogen 61 antihypertensive medications 61 LY# [002] 61 Roche Pegasys 61 chemotherapies 61 desvenlafaxine succinate 61 FASLODEX 61 antitumor activity 61 chemotherapeutic agents 61 cangrelor 61 viral kinetic 61 itraconazole 61 ABC/3TC 61 Actilon 61 interferon alfa 2b 61 lixisenatide 61 virological response 61 mg/m2 dose 61 MabThera rituximab 61 chemotherapeutic agent 61 metastatic malignant 61 adult chronic ITP 61 farletuzumab 61 HBeAg negative patients 61 sapacitabine 61 gadobutrol 61 vidofludimus 61 COPAXONE ® 61 Ramipril 61 BRIM3 61 daptomycin 61 ARCOXIA 61 dasatinib Sprycel 61 TREANDA 61 hepatocellular carcinoma HCC 61 albinterferon alfa 2b 61 voriconazole 61 undetectable HCV RNA 61 Femara 61 AEG# 61 chemotherapeutic regimen 61 lamotrigine 61 #mg QD [001] 61 colesevelam HCl 61 Lantus ® 61 thromboembolic events 61 carfilzomib 61 LEXIVA 61 thalidomide Thalomid 61 Sprycel dasatinib 61 PEG interferon 61 FOLFIRINOX 61 mCi kg 61 metformin monotherapy 61 brain metastases 61 belatacept 61 Arranon 61 tolerability profile 61 baminercept 61 beta blocker therapy 61 hormone refractory prostate cancer 61 FOLFIRI alone 61 paricalcitol 60 Neoadjuvant 60 Quinamed 60 weekly subcutaneous injections 60 #mg/m# [002] 60 MetMAb 60 alefacept 60 terlipressin 60 oral anticoagulants 60 anti TNFs 60 AVADO 60 randomized multicenter Phase III 60 alfa 2a 60 randomized Phase 60 gastrointestinal stromal tumors 60 Noxafil 60 achieve sustained virologic 60 lipid lowering therapy 60 Ribavirin 60 warfarin therapy 60 SYMBICORT 60 VIRAMUNE 60 Peginterferon 60 mg BID 60 chemotherapy gemcitabine 60 PEG IFN 60 LAF# 60 Aclidinium 60 PROCHYMAL 60 Ranolazine 60 esomeprazole 60 Rituxan rituximab 60 TKIs 60 HER2 positive breast cancer 60 imatinib mesylate Gleevec 60 oral antidiabetic medication 60 nucleoside analog 60 Tavocept 60 Glivec 60 EURIDIS 60 liver metastases 60 lipid lowering drugs 60 Protelos 60 tigecycline 60 enoxaparin 60 ascending dose 60 rapamycin 60 phosphate binders 60 acute coronary syndromes ACS 60 metastatic lung cancer 60 investigational compound 60 evaluable patients 60 BENICAR HCT 60 indacaterol 60 efalizumab 60 NeoRecormon 60 RE LY 60 leukotriene receptor antagonist 60 FOLOTYN 60 pCR 60 AZILECT R 60 salmeterol fluticasone 60 atazanavir ritonavir 60 Phase Ib 60 cyclosporine 60 Certican 60 CALGB # [002] 60 depsipeptide 60 non metastatic osteosarcoma 60 Taxol paclitaxel 60 Hepatocellular Carcinoma HCC 60 oral antidiabetic agents 60 follicular lymphoma FL 60 basiliximab 60 biliary tract cancer 60 palifosfamide 60 oral deforolimus 60 celgosivir 60 amoxicillin clavulanate 60 castration resistant prostate cancer 60 TBC# 60 GRASPA ® 60 voreloxin 60 Degarelix 60 Fulvestrant 60 nonrandomized 60 GAMMAGARD 60 #mg BID [001] 60 chemotherapeutic drug 60 cilostazol 60 nesiritide 60 antifungal therapy 60 SCIg 60 epoetin beta 60 rimonabant #mg 60 INCB# [002] 60 Phase 2a trial 60 taxane chemotherapy 60 dirucotide 60 fluticasone salmeterol 60 metastatic pancreatic cancer 60 eribulin 60 rFVIIIFc 60 double blinded placebo 60 NNRTI 60 Gemzar ® 60 Temsirolimus 60 plus COPEGUS 60 Phase IIIb clinical 60 Enzastaurin 60 IFN alpha 60 MGCD# [001] 60 tamsulosin 60 candesartan cilexetil 60 azilsartan medoxomil 60 Tocilizumab 60 Neulasta ® 60 PF # [001] 60 febrile neutropenia 60 SAR# [004] 60 SERCA2a 60 ezetimibe 60 donepezil 60 Erbitux 60 romidepsin 60 odanacatib 60 tremelimumab 60 assessing T DM1 60 temozolomide TMZ 60 dacetuzumab 60 etravirine 60 sulphonylureas 60 imatinib Gleevec ® 60 dronedarone 60 Hepsera 60 DU #b 60 platelet inhibitor 60 splenectomized patients 60 Clolar ® 60 MICARDIS ® 60 docetaxel prednisone 60 Nuvion 60 cancer mCRC 60 INCB# [001] 60 SPRYCEL ® 60 PEG SN# 60 sorafenib Nexavar R 60 ISIS # 60 rituximab Rituxan 60 PREZISTA rtv 60 lipid lowering therapies 60 Tipranavir 60 angiotensin receptor blockers 60 Zerenex 60 paclitaxel poliglumex 60 K ras mutations 60 Gleevec resistant 60 #mg/day [001] 60 adriamycin 60 Omnitarg 60 Rebif ® 60 #mg BID [003] 60 Arixtra 60 Cethromycin 60 tumor recurrence 60 C1 INH 60 Ambrisentan 60 AZD# 60 refractory metastatic colorectal cancer 60 allogeneic SCT 60 dose dose escalation 60 anidulafungin 60 TELINTRA 60 solid tumors 60 EOquin TM 60 atorvastatin